Dallas Attorney Elected Chair of The Leukemia & Lymphoma Society's National Board of Directors
For Immediate Release
Contact: Andrea Greif
Dallas, TX (July 5, 2012) - Timothy S. Durst, a litigation partner in the Dallas office of Baker Botts L.L.P., has been elected chairman of the national Board of Directors of The Leukemia & Lymphoma Society (LLS), effective July 1. LLS is the world's largest voluntary health association dedicated to fighting blood cancer.
At Baker Botts, Durst represents clients in complex business and intellectual property litigation. He has represented clients in a variety of industries, including energy, banking, retail, consumer goods and technology, and has tried cases and handled appeals in state and federal courts and before arbitration panels. He is chair of the firm's Dallas litigation department. Baker Botts' lawyers and employees have supported LLS for years through volunteer and fund raising efforts, including currently being a national partner for LLS's Light The Night® Walk campaign.
Durst has served in several capacities with LLS, beginning in 1999 during his son's successful treatment for leukemia, including vice chair of the national Board of Directors, and president of LLS's North Texas Chapter. Among his responsibilities as chairman, Durst will preside over meetings of the national Board of Directors, work to establish and implement strategies, goals and objectives for LLS, represent LLS in various public and private settings, and act as the Board's primary liaison to the CEO. The national Board of Directors is charged with exercise of corporate powers, including governance and conducting the business and affairs of the not-for-profit corporation. Durst's term as chair is two years.
"I am honored that my colleagues on the board have elected me to this position," said Durst. "I look forward to doing everything I can to help advance the LLS mission."
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
LLS is a New York not-for-profit corporation. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.lls.org or contact the Information Resource Center at (800) 955-4572.